These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5824354)

  • 41. The anti-hypoxaemic effect of cyclandelate in man measured in human volunteers using computer-assisted oculodynamic methodology.
    Schaffler K
    Br J Clin Pract Suppl; 1984; 34():51-7. PubMed ID: 6430324
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of cyclandelate, isoxsuprine and nylidrin on hyperventilation build-up in the electroencephalogram of volunteer subjects.
    Whittier JR; Dhrymiotis A
    Angiology; 1965 Oct; 16(10):575-9. PubMed ID: 5320076
    [No Abstract]   [Full Text] [Related]  

  • 43. Transient ischemic attack: an early warning system for stroke?
    Greenhouse AH
    Geriatrics; 1973 Sep; 28(9):134-9. PubMed ID: 4725689
    [No Abstract]   [Full Text] [Related]  

  • 44. Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38 485.
    Türker RK; Egemen N; Deda H
    Prog Clin Biol Res; 1989; 301():205-9. PubMed ID: 2477851
    [No Abstract]   [Full Text] [Related]  

  • 45. Investigation into 3.5.5-trimethylcyclohexyl mandelate (cyclospasmol).
    EIJKEL G; ERNSTING MJ; REKKER RF; NAUTA WT
    Pharm Weekbl; 1956 Feb; 91(3):81-90. PubMed ID: 13310218
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.
    Handa Y; Yoneda S; Koyama T; Matsuda M; Handa H
    Surg Neurol; 1975 Apr; 3(4):195-9. PubMed ID: 1145417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 48. [Metabolites of cyclandelate. Vasodilator action and inhibition of phosphodiesterase by metabolites of cyclandelate].
    Himber J; De Burlet G; Andermann G
    Ann Pharm Fr; 1987; 45(3):233-41. PubMed ID: 3434974
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cerebral vasospasm. The cerebral arterial spasm of subarachnoid hemorrhage--a new hemodynamic dimension].
    Pendefunda L; Georgescu EM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(4):649-54. PubMed ID: 3253916
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of atherosclerosis in the rabbit by cyclandelate.
    Middleton A; Edwards E; White DA; Middleton B
    Br J Clin Pract Suppl; 1984; 34():39-42. PubMed ID: 6430322
    [No Abstract]   [Full Text] [Related]  

  • 51. [Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency].
    Foltyn P; Lücker PW; Schnitker J
    Arzneimittelforschung; 1982; 32(10):1322-8. PubMed ID: 6891235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483
    [No Abstract]   [Full Text] [Related]  

  • 53. [A preliminary report of treatment of transient cerebral ischemic attacks with BL 191 (author's transl)].
    Chen HB
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Feb; 13(2):97-9. PubMed ID: 7428559
    [No Abstract]   [Full Text] [Related]  

  • 54. Benefits of cyclandelate in the treatment of disorders of ageing.
    Le Poncin-Lafitte M
    Br J Clin Pract Suppl; 1984; 34():58-61. PubMed ID: 6430325
    [No Abstract]   [Full Text] [Related]  

  • 55. Specific effects of cyclandelate on memory.
    Ananth J
    Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes.
    Van den Hoven WE; Hall DW; Burns JW
    Br J Clin Pract Suppl; 1984; 34():26-30. PubMed ID: 6430318
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of drugs on oxygen availability for the cerebral cortex in rabbits.
    Tagawa Y
    Kumamoto Med J; 1973 Sep; 26(3):97-106. PubMed ID: 4789162
    [No Abstract]   [Full Text] [Related]  

  • 58. [Some peculiarities of hyperventilation during ether-oxygen anesthesia in the light of electroencephalographic, rheographic and electrocardiographic indices].
    Efuni SN; Gebel' GIa; Trekova NA; Perestoronin SA
    Khirurgiia (Mosk); 1965 Aug; 41(8):35-41. PubMed ID: 5878543
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
    Albizzati MG; Bassi S; Sbacchi M; Frattola L
    Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice.
    de Halleux F
    Drugs; 1987; 33 Suppl 2():114-9. PubMed ID: 3622305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.